Talk with European Commission
The European Commission wants to deal with Moderna for the vaccine. Deals are being made for the purchase of less than $ 25 for millions of doses. Bainsall has said that nothing final has been done yet but talks are on. He said the company wants to deliver in Europe and talks are continuing in a positive direction. The deal between the two has been going on since July.
Earlier Moderna reported that its vaccine is 94.5% effective at stopping Kovid-19. The announcement was finally made on the basis of interim data from stage clinical trials. Apart from Moderna, only Pfizer has given so many successful results. Moderna’s vaccine is also based on the same mRNA technique as the Pfizer vaccine. Moderna’s vaccine produced antibodies in the young as well as older people, which led to action against the virus.
Pfizer seeks FDA approval
Pfizer has applied to the US regulatory authority for permission to use its Corona virus vaccine in emergency. It is believed that on completion of this procedure, a limited number of vaccine supplements may be ready next month. The company has said that with the protection from the virus and not having serious side effects, the vaccine may apply for permission to use the Food and Drug Administration (FDA) for use. After this, its final testing can also be done.
Oxford Vaccine Will Come By Christmas?
Professor Andrew Pollard, leader of the Vaccine Trial at Oxford University and AstraZeneca, says the team expects the vaccine to be approved by Christmas. He says that it will be 10 times cheaper than Pfizer. Actually, the Pfizer vaccine has to be kept at a temperature of -70 ° C and two injections will be made at a difference of few weeks. The Oxford vaccine has to be kept at fridge temperature.